BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qiu J, Zheng Q, Meng X. Hyperglycemia and Chemoresistance in Breast Cancer: From Cellular Mechanisms to Treatment Response. Front Oncol 2021;11:628359. [PMID: 33718202 DOI: 10.3389/fonc.2021.628359] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
Number Citing Articles
1 Yilmaz H, Nigdelioglu B, Aytac A, Turan M, Oktay E, Yersal O, Barutca S. The prognostic importance of glucose-to-lymphocyte ratio and uric acid in metastatic breast cancer patients treated with Cdk 4/6 inhibitors. Future Oncol 2022. [PMID: 36062468 DOI: 10.2217/fon-2022-0464] [Reference Citation Analysis]
2 Hussain Y, Khan H, Alam W, Aschner M, Abdullah, Alsharif KF, Saso L. Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy. Oxid Med Cell Longev 2022;2022:4831833. [PMID: 35795855 DOI: 10.1155/2022/4831833] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Temre MK, Yadav S, Goel Y, Pandey SK, Kumar A, Singh SM. Glutor, a Glucose Transporter Inhibitor, Exerts Antineoplastic Action on Tumor Cells of Thymic Origin: Implication of Modulated Metabolism, Survival, Oxidative Stress, Mitochondrial Membrane Potential, pH Homeostasis, and Chemosensitivity. Front Oncol 2022;12:925666. [DOI: 10.3389/fonc.2022.925666] [Reference Citation Analysis]
4 Wright GM, Gassman NR. Glucose Increases STAT3 Activation, Promoting Sustained XRCC1 Expression and Increasing DNA Repair. Int J Mol Sci 2022;23:4314. [PMID: 35457130 DOI: 10.3390/ijms23084314] [Reference Citation Analysis]
5 Tankova T, Senkus E, Beloyartseva M, Borštnar S, Catrinoiu D, Frolova M, Hegmane A, Janež A, Krnić M, Lengyel Z, Marcou Y, Mazilu L, Mrinakova B, Percik R, Petrakova K, Rubovszky G, Tokar M, Vrdoljak E. Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer. Cancers (Basel) 2022;14:1598. [PMID: 35406370 DOI: 10.3390/cancers14071598] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Fakhri S, Moradi SZ, Yarmohammadi A, Narimani F, Wallace CE, Bishayee A. Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy. Front Oncol 2022;12:834072. [PMID: 35299751 DOI: 10.3389/fonc.2022.834072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Cejuela M, Martin-Castillo B, Menendez JA, Pernas S. Metformin and Breast Cancer: Where Are We Now? Int J Mol Sci 2022;23:2705. [PMID: 35269852 DOI: 10.3390/ijms23052705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules 2022;27:705. [PMID: 35163973 DOI: 10.3390/molecules27030705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
9 Soni VK, Mehta A, Ratre YK, Chandra V, Shukla D, Kumar A, Vishvakarma NK. Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells. Front Oncol 2021;11:738961. [PMID: 34692517 DOI: 10.3389/fonc.2021.738961] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Zhang N, Xue M, Wang Q, Liang H, Yang J, Pei Z, Qin K. Inhibition of fucoidan on breast cancer cells and potential enhancement of their sensitivity to chemotherapy by regulating autophagy. Phytother Res 2021. [PMID: 34687482 DOI: 10.1002/ptr.7303] [Cited by in F6Publishing: 5] [Reference Citation Analysis]